מכפיל P/S עתידי: InMode (INMD)
The expected P/S ratio demonstrates a trend where 1.90 records a new level. Aggressive sales and high bonuses for B2B specialists support this growth. High profitability allows InMode Ltd. (INMD) to maintain its staff of Israeli development engineers. Business efficiency is based on strict cost control and the regular release of innovative radiofrequency devices for aesthetic medicine.
פילוחי נתונים אנליטיים מרוכזים עבור InMode MD (INMD)
InMode Ltd. is transforming aesthetic medicine through minimally invasive radiofrequency technologies, which directly impacts expected sales dynamics. The forward P/S ratio compares the current market value of the business with projected annual revenue, revealing whether the asset is overvalued or undervalued. This indicator measures market expectations, allowing investors to identify entry points when multiples are depressed. The history of forward P/S changes helps synchronize capitalization with the actual pace of innovation expansion.
